Dr Forrest Marc Stewart, MD - Medicare Hematology in Duarte, CA

Dr Forrest Marc Stewart, MD is a medicare enrolled "Internal Medicine - Hematology" physician in Duarte, California. He graduated from medical school in 1977 and has 47 years of diverse experience with area of expertise as Hematology. He is a member of the group practice City Of Hope Medical Foundation and his current practice location is 1500 Duarte Rd, Duarte, California. You can reach out to his office (for appointments etc.) via phone at (626) 256-4673.

Dr Forrest Marc Stewart is licensed to practice in California (license number C169125) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1750436788.

Contact Information

Dr Forrest Marc Stewart, MD
1500 Duarte Rd,
Duarte, CA 91010-3012
(626) 256-4673
Not Available



Physician's Profile

Full NameDr Forrest Marc Stewart
GenderMale
SpecialityHematology
Experience47 Years
Location1500 Duarte Rd, Duarte, California
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Forrest Marc Stewart graduated from medical school in 1977
  NPI Data:
  • NPI Number: 1750436788
  • Provider Enumeration Date: 01/23/2007
  • Last Update Date: 12/02/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 8426960329
  • Enrollment ID: I20200722001946

Medical Identifiers

Medical identifiers for Dr Forrest Marc Stewart such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1750436788NPI-NPPES
1750436788MedicaidWA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RH0003XInternal Medicine - Hematology & Oncology MD00039212 (Washington)Secondary
207RH0000XInternal Medicine - Hematology C169125 (California)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
City Of Hope Medical Foundation3779751656686

News Archive

Early testing for influenza symptoms can limit severe, life-threatening disease

As flu season picks up steam across the country, it's important for people to be tested very early after symptoms that are compatible with influenza start, since there are effective treatments that can limit severe, life-threatening disease and curtail transmission to others.

Stem Cell Therapy International to merge with Histostem Korea

Stem Cell Therapy International Inc. (OTCBB: SCII) announced today that the Company has agreed to be a party to the settlement between Histostem, Incorporated, a Delaware Corporation ("Histostem USA") and Histostem Corporation, a Korean Corporation ("Histostem Korea"). The agreement is contingent upon the close of the SCII and Histostem Korea merger, and specifically, the agreement is contingent that at the close of the merger, SCII will acquire no less than 90% of the total fully diluted equity of Histostem Korea.

New project identifies immune checkpoint inhibition as potential treatment for angiosarcomas

Angiosarcoma Project, a patient-partnered genomics study, identified immune checkpoint inhibition as a potential treatment option for patients with angiosarcomas of the head, face, neck, or scalp, according to data presented at the fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference.

Transmembrane protein NG2 controls orientation of cell migration toward the wound

When the central nervous system is injured, oligodendrocyte precursor cells migrate to the lesion and synthesize new myelin sheaths on demyelinated axons. Scientists at the Institute of Molecular Cell Biology at Johannes Gutenberg University Mainz have now discovered that a distinct protein regulates the direction and movement of OPC toward the wound. The transmembrane protein NG2, which is expressed at the surface of OPCs and down-regulated as they mature to myelinating oligodendrocytes, plays an important role in the reaction of OPC to wounding.

Intel's CTO says technology will bring man and machine much closer together by 2050

Intel Corporation's chief technology officer took a fascinating look at how technology will bring man and machine much closer together by 2050.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Forrest Marc Stewart allows following entities to bill medicare on his behalf.
Entity NameCity Of Hope Medical Foundation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1871886366
PECOS PAC ID: 3779751656
Enrollment ID: O20110720000244

News Archive

Early testing for influenza symptoms can limit severe, life-threatening disease

As flu season picks up steam across the country, it's important for people to be tested very early after symptoms that are compatible with influenza start, since there are effective treatments that can limit severe, life-threatening disease and curtail transmission to others.

Stem Cell Therapy International to merge with Histostem Korea

Stem Cell Therapy International Inc. (OTCBB: SCII) announced today that the Company has agreed to be a party to the settlement between Histostem, Incorporated, a Delaware Corporation ("Histostem USA") and Histostem Corporation, a Korean Corporation ("Histostem Korea"). The agreement is contingent upon the close of the SCII and Histostem Korea merger, and specifically, the agreement is contingent that at the close of the merger, SCII will acquire no less than 90% of the total fully diluted equity of Histostem Korea.

New project identifies immune checkpoint inhibition as potential treatment for angiosarcomas

Angiosarcoma Project, a patient-partnered genomics study, identified immune checkpoint inhibition as a potential treatment option for patients with angiosarcomas of the head, face, neck, or scalp, according to data presented at the fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference.

Transmembrane protein NG2 controls orientation of cell migration toward the wound

When the central nervous system is injured, oligodendrocyte precursor cells migrate to the lesion and synthesize new myelin sheaths on demyelinated axons. Scientists at the Institute of Molecular Cell Biology at Johannes Gutenberg University Mainz have now discovered that a distinct protein regulates the direction and movement of OPC toward the wound. The transmembrane protein NG2, which is expressed at the surface of OPCs and down-regulated as they mature to myelinating oligodendrocytes, plays an important role in the reaction of OPC to wounding.

Intel's CTO says technology will bring man and machine much closer together by 2050

Intel Corporation's chief technology officer took a fascinating look at how technology will bring man and machine much closer together by 2050.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Forrest Marc Stewart is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Forrest Marc Stewart, MD
Po Box 512185,
Los Angeles, CA 90051-0185

Ph: () -
Dr Forrest Marc Stewart, MD
1500 Duarte Rd,
Duarte, CA 91010-3012

Ph: (626) 256-4673

News Archive

Early testing for influenza symptoms can limit severe, life-threatening disease

As flu season picks up steam across the country, it's important for people to be tested very early after symptoms that are compatible with influenza start, since there are effective treatments that can limit severe, life-threatening disease and curtail transmission to others.

Stem Cell Therapy International to merge with Histostem Korea

Stem Cell Therapy International Inc. (OTCBB: SCII) announced today that the Company has agreed to be a party to the settlement between Histostem, Incorporated, a Delaware Corporation ("Histostem USA") and Histostem Corporation, a Korean Corporation ("Histostem Korea"). The agreement is contingent upon the close of the SCII and Histostem Korea merger, and specifically, the agreement is contingent that at the close of the merger, SCII will acquire no less than 90% of the total fully diluted equity of Histostem Korea.

New project identifies immune checkpoint inhibition as potential treatment for angiosarcomas

Angiosarcoma Project, a patient-partnered genomics study, identified immune checkpoint inhibition as a potential treatment option for patients with angiosarcomas of the head, face, neck, or scalp, according to data presented at the fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference.

Transmembrane protein NG2 controls orientation of cell migration toward the wound

When the central nervous system is injured, oligodendrocyte precursor cells migrate to the lesion and synthesize new myelin sheaths on demyelinated axons. Scientists at the Institute of Molecular Cell Biology at Johannes Gutenberg University Mainz have now discovered that a distinct protein regulates the direction and movement of OPC toward the wound. The transmembrane protein NG2, which is expressed at the surface of OPCs and down-regulated as they mature to myelinating oligodendrocytes, plays an important role in the reaction of OPC to wounding.

Intel's CTO says technology will bring man and machine much closer together by 2050

Intel Corporation's chief technology officer took a fascinating look at how technology will bring man and machine much closer together by 2050.

Read more News

› Verified 4 days ago


Internal Medicine Doctors in Duarte, CA

Sasan Fazeli, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1500 Duarte Rd, Duarte, CA 91010
Phone: 626-256-4673    Fax: 626-408-3911
Mr. Yun Yen, MD
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1500 E Duarte Rd, Duarte, CA 91010
Phone: 626-359-8111    
Dr. Randy Allison Taplitz, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1500 Duarte Rd, Duarte, CA 91010
Phone: 626-256-4673    
Dr. Liying Cai, M.D., PH.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1500 Duarte Rd, Duarte, CA 91010
Phone: 626-256-4673    
Peter Poon-hang Lee, MD
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 1500 Duarte Rd, Duarte, CA 91010
Phone: 626-359-8111    
Dr. Sharonlin Bhardwaj, M.D.
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 1500 Duarte Rd, Duarte, CA 91010
Phone: 626-256-4673    
Dr. Martin Valera Consunji, MD
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 1500 Duarte Rd, Duarte, CA 91010
Phone: 626-256-4673    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.